TISSIUM Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 140

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 14

TISSIUM General Information

Description

Developer of biodegradable programmable polymer technology designed for tissue reconstruction and adaptable for use in multiple clinical areas. The company's technology uses biomorphic reconstructive polymers for biodegradable sealants and adhesives for surgical-wound closure that are non-toxic, designed to bind strongly to tissues and deliver immediate wound closure within the environments of the body, enabling surgeons to treat patients with a polymer that can be used in the fields of tissue repair and localized drug delivery.

Contact Information

Website
www.tissium.com
Formerly Known As
Gecko Biomedical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 18 Avenue Léon Gaumont
  • 75020 Paris
  • France
+33 01
Primary Industry
Surgical Devices
Vertical(s)
Corporate Office
  • 18 Avenue Léon Gaumont
  • 75020 Paris
  • France
+33 01

TISSIUM Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TISSIUM Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Accelerator/Incubator 15-Jun-2026 Completed Generating Revenue
12. Later Stage VC (Series D2) 23-Nov-2025 Completed Generating Revenue
11. Accelerator/Incubator 05-Jun-2025 Completed Generating Revenue
10. Grant 15-Jun-2023 Completed Generating Revenue
9. Later Stage VC (Series D) 23-May-2023 Completed Generating Revenue
8. Accelerator/Incubator 01-Feb-2022 Completed Generating Revenue
7. Later Stage VC (Series C) 31-Aug-2021 Completed Generating Revenue
6. Debt - General 01-Oct-2020 Completed Pre-Clinical Trials
5. Later Stage VC (Series B) 20-Nov-2019 $43M $79.4M Completed Pre-Clinical Trials
4. Grant 24-Jan-2018 $7.26M $36.4M Completed Pre-Clinical Trials
To view TISSIUM’s complete valuation and funding history, request access »

TISSIUM Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
D Shares
C Shares
B Shares
A2 Shares 499,998 $0.010972 $49.37 $49.37 1x $49.37 2.08%
A Shares 210,526 $0.010972 $41.69 $41.69 1x $41.69 0.88%
To view TISSIUM’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TISSIUM Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biodegradable programmable polymer technology designed for tissue reconstruction and adaptable for use in m
Surgical Devices
Paris, France
140 As of 2026

Indianapolis, IN
 

Saint-Priest, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TISSIUM Competitors (10)

One of TISSIUM’s 10 competitors is Nico (Surgical Devices), a Formerly VC-backed company based in Indianapolis, IN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nico (Surgical Devices) Formerly VC-backed Indianapolis, IN
Biom'Up Formerly VC-backed Saint-Priest, France
Artivion Formerly PE-Backed Kennesaw, GA
Apyx Medical Corporation Clearwater, FL
Medtronic Corporation Minneapolis, MN
You’re viewing 5 of 10 competitors. Get the full list »

TISSIUM Patents

TISSIUM Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026124775-A1 Sealing disposable for a medical light application device Pending 12-Dec-2024
WO-2026125761-A1 Sealing disposable for a medical light application device Pending 12-Dec-2024
EP-4744896-A1 Composition comprising pre-polymer Pending 15-Nov-2024
WO-2026104575-A1 Composition comprising pre-polymer Pending 15-Nov-2024
EP-4745175-A1 Composition comprising pre-polymer with improved mechanical properties Pending 15-Nov-2024 C08G18/4244
To view TISSIUM’s complete patent history, request access »

TISSIUM Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TISSIUM Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
ISALT- Strategic Long Term Equity Investments PE/Buyout Minority
Merieux Equity Partners (Lyon) PE/Buyout Minority
La French Tech Accelerator/Incubator
Cathay Capital PE/Buyout Minority
Cathay Health Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

TISSIUM FAQs

  • When was TISSIUM founded?

    TISSIUM was founded in 2013.

  • Where is TISSIUM headquartered?

    TISSIUM is headquartered in Paris, France.

  • What is the size of TISSIUM?

    TISSIUM has 140 total employees.

  • What industry is TISSIUM in?

    TISSIUM’s primary industry is Surgical Devices.

  • Is TISSIUM a private or public company?

    TISSIUM is a Private company.

  • What is TISSIUM’s current revenue?

    The current revenue for TISSIUM is .

  • How much funding has TISSIUM raised over time?

    TISSIUM has raised $271M.

  • Who are TISSIUM’s investors?

    ISALT- Strategic Long Term Equity Investments, Merieux Equity Partners (Lyon), La French Tech, Cathay Capital, and Cathay Health are 5 of 14 investors who have invested in TISSIUM.

  • Who are TISSIUM’s competitors?

    Nico (Surgical Devices), Biom'Up, Artivion, Apyx Medical, and Medtronic are some of the 10 competitors of TISSIUM.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process